Related Experiment Videos
A method for rapid detection of arylsulfatase A pseudodeficiency mutations
M H Ricketts1, X Zhang, P Manowitz
1Department of Psychiatry, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, N.J. 08854, USA.
Human Heredity
|July 1, 1995
Summary
A new DNA test accurately detects arylsulfatase A pseudodeficiency, simplifying metachromatic leukodystrophy risk assessment. This method aids in determining carrier status and provides crucial genetic counseling for affected families.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Pseudodeficiency of arylsulfatase A complicates accurate diagnosis of metachromatic leukodystrophy (MLD).
- Accurate carrier status determination for MLD is essential for genetic counseling.
- Existing methods may be hindered by pseudodeficiency alleles.
Purpose of the Study:
- To develop and describe a molecular method for detecting arylsulfatase A pseudodeficiency mutations.
- To facilitate accurate MLD risk and carrier status assessment.
- To improve genetic counseling for families with potential MLD or pseudodeficiency.
Main Methods:
- Utilizing DNA extracted from blood or buccal cells.
- Employing polymerase chain reaction (PCR) for DNA amplification.
- Using restriction enzyme digestion to identify specific pseudodeficiency mutations.
Main Results:
- A reliable method for detecting both common arylsulfatase A pseudodeficiency mutations was established.
- The technique allows for differentiation between true MLD and pseudodeficiency states.
- Successful application demonstrated using DNA from various sources.
Conclusions:
- The described PCR and restriction digestion method effectively identifies arylsulfatase A pseudodeficiency.
- This diagnostic tool enhances the accuracy of MLD risk and carrier status evaluation.
- The method supports informed genetic counseling in families with pseudodeficiency alleles.